The global statistics are terrifying. Prostate cancer is the fourth most common cancer in all populations, the second most ...

Prostate cancer is the most prevalent cancer in Australia. This article discusses the limitations of PSA tests in determining ...

Pedro C. Barata, MD, MSc, discusses the advantages and disadvantages of darolutamide in metastatic hormone-sensitive prostate ...

A stage-four cancer diagnosis once sounded like the end of the road – after all, there is no stage five. When Joe Biden’s ...

Prostate cancer is a significant health concern for men worldwide, with increasing diagnoses and fatalities projected. Early detection and treatment a ...

I am a 53-year-old healthy male, and I always request to check my PSA levels each year. My 57-year-old brother’s new doctor ...

Jacob E. Berchuck, MD, highlights novel findings pointing to androgen receptor signaling and Wnt pathway activation as key ...

A new research paper was published in Volume 16 of Oncotarget on June 25, 2025, titled "Hypoxia induced lipid droplet ...

A new research paper was published in Volume 16 of Oncotarget on June 25, 2025, titled “Hypoxia induced lipid droplet accumulation promotes resistance to ferroptosis in prostate cancer.” ...

Androgen deprivation therapy (ADT) has long been a foundation in the management of prostate cancer. Since the introduction of ...